Medical Causes of Hospitalisation among Patients with Bronchiectasis: A Nationwide Study in Japan
Open Access
Abstract
Purpose: Although the international guidelines for managing bronchiectasis are centred on preventing the exacerbation of bronchiectasis, the medical causes of admissions to hospital among patients with bronchiectasis have not been fully investigated. Methods: This study targeted patients with bronchiectasis who were admitted to hospitals between April 2018 and March 2020 using the national inpatient database in Japan. The causes of hospitalisation and types of antibiotics used for hospitalised patients were recorded. Results: In total, 21,300 hospitalisations of 16,723 patients with bronchiectasis were analysed. The most common cause was respiratory diseases in 15,145 (71.1%) admissions, including bacterial pneumonia and the exacerbation of bronchiectasis in 6238 (41.2%) and 3151 (20.8%), respectively. Antipseudomonal antibiotics were used in approximately 60% of patients with bacterial pneumonia who were administered antibiotic treatments and in approximately 50% of patients with the exacerbation of bronchiectasis. Conclusions: Bacterial pneumonia was the most frequent cause of hospitalisation, followed by the exacerbation of bronchiectasis, among patients with bronchiectasis. Physicians need to focus on the prevention of bacterial pneumonia in addition to the exacerbation of bronchiectasis in patients with bronchiectasis.Keywords
This publication has 45 references indexed in Scilit:
- Efficacy and safety of macrolide therapy for adult asthma: A systematic review and meta-analysisRespiratory Investigation, 2024
- Types of cancer and outcomes in patients with cancer requiring admission from the emergency department: A nationwide, population‐based study, 2016‐2017Cancer, 2021
- Characteristics and Health-care Utilization History of Patients With Bronchiectasis in US Medicare Enrollees With Prescription Drug Plans, 2006 to 2014Chest, 2018
- Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary diseaseCochrane Database of Systematic Reviews, 2017
- An analysis of etiology, causal pathogens, imaging patterns, and treatment of Japanese patients with bronchiectasisRespiratory Investigation, 2015
- The role of the microbiome in exacerbations of chronic lung diseasesThe Lancet, 2014
- Effect of Long-term, Low-Dose Erythromycin on Pulmonary Exacerbations Among Patients With Non–Cystic Fibrosis BronchiectasisJAMA, 2013
- Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trialThe Lancet, 2012
- Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in JapanVaccine, 2010
- Characterisation of the onset and presenting clinical features of adult bronchiectasisRespiratory Medicine, 2006